Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 12, 2003. The report details a specific corporate action regarding share repurchases authorized by shareholders at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to a specific share buyback transaction:
- Shares Purchased: 500,000 Ordinary 25 pence shares.
- Purchase Price: 1,210.85 pence per share.
- Transaction Date: August 12, 2003.
- Outcome: Shares were purchased for cancellation.
Material Changes
The filing does not report material changes in operating results or financial position compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 500,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document is strictly a notification of the share repurchase execution.
Investor Verification Points
- Verify the total number of shares remaining outstanding following the cancellation of 500,000 shares.
- Confirm the total capital expenditure for this specific buyback (500,000 shares x 1,210.85 pence).
- Check subsequent filings for the remaining authority available under the May 19, 2003 shareholder mandate.